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Abstract
Sclerosing mesenteritis (SM) is a rare inflammatory and fibrosing disease primarily involving the small-bowel
mesentery. Recently, SM was reported to be closely related to IgG4-related disease (IgG4-RD). This report
describes a patient with SM associated with IgG4-RD. A 77-year-old woman with a history of surgery for
ectopic pregnancy and wound dehiscence presented with intestinal obstruction. Abdominal enhanced
computed tomography (CT) revealed an enhanced, radially shaped, oval mass, 3 cm in diameter, with an
unclear rim in the mesentery of the distal ileum, which may have involved the distal ileum. To remove the
cause of bowel obstruction, the SM was resected completely and the ileum was resected partially. Histologic
examination showed that the mass was composed of spindle cells arranged in a fascicular or storiform
pattern; moreover, fibrous stroma was observed, with dense lymphoplasmacytic infiltration and lymphoid
follicles. Immunohistochemically, numerous IgG4-positive plasma cells were observed, at a density of 253 per
high-powered field, and the IgG4/IgG ratio was about 50 %. Elastica van Gieson (EVG) staining also showed
obstructive phlebitis. These findings indicated IgG4-related SM. Although the accurate diagnosis of SM remains
difficult without histological analysis, IgG4-RD should be included in the differential diagnosis of unknown
mesenteric tumors. Identification of IgG4-RD may prevent unnecessary surgery because corticosteroids may
be effective in these patients.
Keywords: IgG4-related SM, Sclerosing mesenteritis, Intestinal obstruction
Background
Sclerosing mesenteritis (SM) is a rare inflammatory and
fibrosing disease of unknown etiology that primarily
involves the small-bowel mesentery, most frequently
observed in middle-aged and older men [1–6]. SM, also
called mesenteric fibrosis, mesenteric lipodystrophy, and
retractile mesenteritis, is histologically characterized by
varying degrees of fibrosis, chronic inflammation, and
fat necrosis [1]. On imaging, SM appears as a well- or
ill-defined mass in the mesentery, which may be clini-
cally misdiagnosed as a malignant neoplasm [7–9].
SM was recently reported to be closely related to
IgG4-related disease (IgG4-RD) [2, 10–13], a systemic
syndrome characterized by masses in various organs
infiltrated by IgG4-positive plasma cells and high serum
IgG4 concentrations [14, 15]. This report describes a
patient with IgG4-related SM causing bowel obstruction.
Case presentation
A 77-year-old woman, who had a history of surgery for
ectopic pregnancy and wound dehiscence 28 years earl-
ier, presented to another hospital with intermittent
abdominal pain. She was diagnosed with an intestinal
obstruction and admitted to the hospital. Computed
tomography (CT) revealed an irregularly shaped mass,
3 cm in diameter, in the mesentery of the ileum, which
was suspected of causing her bowel obstruction. Medical
treatment, including long-tube decompression, improved
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her symptoms, and she was referred to our hospital for
further examination and treatment.
On admission to our hospital, she had no symptoms
and a physical examination showed no abnormalities.
Laboratory tests, including those for tumor markers
such as CEA and CA19-9, showed no abnormalities. Her
serum IgG4 concentration was not measured. Abdo-
minal enhanced CT imaging revealed an enhanced, radi-
ally shaped, oval mass, 3 cm in diameter, with an unclear
rim in the mesentery of the distal ileum, which may have
involved the distal ileum (Fig. 1). Double balloon entero-
scopy and gastrografin enterography showed no abnor-
mal findings. As seen in Fig. 2, 18F-fluorodeoxyglucose
positron emission tomography (FDG-PET) revealed a
slight uptake of fluorodeoxyglucose (standardized uptake
value 4.4) by the mass. These findings could not yield an
accurate diagnosis, including whether the mass was
malignant or inflammatory.
It was therefore decided to perform surgery, both to
remove the cause of bowel obstruction and diagnose it
pathologically. A midline incision was made, along with
careful adhesiolysis for the tight adhesions over almost
the entire intra-abdominal space resulting from the
previous surgery. An elastic-hard yellowish mesenteric
mass, involving the adjacent ileum, was detected (Fig. 3a).
A partial ileal resection that included the mass was
performed, followed by hand-sewn ileo-ileal anastomosis.
Macroscopic examination showed a radially shaped
tumor with an unclear rim at the root of the mesentery.
The cut surface of the resected specimen showed in-
flammatory fat tissue containing white fibrous strands
(Fig. 3b). Microscopically, the mass was composed of
spindle cells in a fascicular or storiform pattern and
fibrous stroma with lymphoplasmacytic infiltration and
lymphoid follicles (Fig. 4a,b). Elastica van Gieson (EVG)
staining showed obstructive phlebitis (Fig. 4c). Immu-
nohistochemical examination showed numerous IgG4-
positive plasma cells, with an IgG4/IgG ratio of 50 %
(Fig. 4d). Immunohistochemically, the spindle cells were
negative for anaplastic lymphoma kinase (ALK), desmin,
CDK4, MDM2, CD21, CD35, and nuclear β-catenin,
whereas the lymphocytes in inter-lymphoid follicles
were positive for CD3 and the lymphocytes in germinal
centers were positive for CD20. These findings indicated a
diagnosis of IgG4-related SM, while excluding diagnoses
of leiomyosarcoma, inflammatory myofibroblastic tumor,
desmoids tumor, liposarcoma, and follicular dendritic tumor.
The patient’s serum IgG4 concentration 19 days after surgery
was 114 mg/dl (normal range, 4.8–105 mg/dl). Further
postoperative examination showed no evidence of IgG4-
RD of other organs, including the pancreas and salivary
glands. After follow-up for 4 years, there has been no
evidence of SM recurrence or symptom relapse.
Discussion
This report describes a patient with symptomatic SM as
a manifestation of IgG4-RD. Because of its rarity, the
etiology of SM remains undetermined [1–6]. Suggested
causes include trauma (including surgery), powder on
surgical gloves, infection (such as tuberculosis), auto-
immune diseases, vascular insufficiency, and retained
suture material [1–3]. About 40 to 70 % of patients with
SM were found to have undergone previous surgery [1, 2].
Similarly, the patient described in this report had a history
of surgery for ectopic pregnancy and wound dehiscence
28 years earlier. During surgery for SM, tight adhesions
were seen throughout her abdomen. The pathogenic
mechanism of SM seems to be a non-specific response to
a wide variety of stimuli.
SM may be an IgG4-RD [10–13], diseases that drama-
tically respond to corticosteroid treatment [14, 15].
Recently, IgG4-RD was reported to be closely related to
Fig. 1 Abdominal enhanced CT, showing a radial, irregularly shaped
mass (white arrow), 26 mm in diameter, at the root of the mesentery
in the right lower quadrant and located close to the ileum
Fig. 2 PET-CT scan, showing abnormal uptake of fluorodeoxyglucose
by the mass (white arrow; SUVmax = 4.4)
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multifocal fibrosclerosis [14]. IgG4-RD is characterized
by organ enlargement and nodular/hyperplastic lesions
in various organs, either concurrently or metachronously,
due to marked infiltration of lymphocytes and IgG4-
positive plasma cells, as well as to fibrosis of unknown
etiology [14, 15]. Although the incidence of SM related to
IgG4-RD has not been determined, SM was observed in 2
(4 %) of 57 patients with autoimmune pancreatitis [3] and
marked infiltration of IgG4-positive plasma cells was
observed in 4 (33 %) of 12 patients with SM [2]. The com-
prehensive diagnostic criteria for IgG4-RD [15] require
imaging and serum and histopathological examination. (1)
Clinical examination should show characteristic diffuse/
localized swelling or masses in single or multiple organs.
(2) Hematological examination should show elevated
serum IgG4 concentration (≥135 mg/dl). (3) Histopatho-
logic examination should show marked lymphoplasma-
cytic infiltration, lymphoid follicles, obstructive phlebitis,
dense fibrosis, and infiltration of IgG4-positive plasma
cells.
The rate of IgG4- and IgG-positive cells diagnostic of
IgG4-RD has been defined as >40 to 50 %, with >60 to
100 IgG4-positive cells present per high-powered field
(HPF) [16]. The degree of infiltration of IgG4- and IgG-
positive plasma cells is analyzed in areas with the highest
density of positive cells, with three HPFs evaluated in
each patient and averaged [16]. The postoperative serum
IgG4 concentration in our patient was 114 mg/dl, higher
Fig. 3 Intraoperative findings in the patient. a An elastic soft, yellowish white-like mass (arrow) was observed at the root of the mesentery, with
the mass also involving the adjacent ileum. b View of the cut surface of the resected specimen, showing inflammatory fat tissue containing white
fibrous strands
Fig. 4 Histological examination of tissue specimens. a, b Hematoxylin and eosin staining, showing that the mass was composed of a prominent
lymphoid follicles with sclerosis and b fascicular or storiform proliferation of spindle cells with inflammatory cells. c Elastica van Gieson (EVG)
staining, showing obliterative phlebitis. d Immunohistochemical staining with anti-IgG4 antibody, showing that numerous IgG4-positive plasma
cells were observed (253 per high-powered field (HPF); IgG4/IgG ratio = 50 %)
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than the normal range (4.8–105 mg/dl), but lower than
the cutoff of 135 mg/dl. Thus, according to the above
criteria, this patient should be diagnosed as having
“probable” IgG4-RD.
A search of PubMed using “IgG4” and “sclerosing
mesenteritis” as key words resulted in seven cases that
seemed to be IgG4-related sclerosing mesenteritis [10–13,
17–19]. These seven cases and the present case are sum-
marized in Table 1. The chief complaint was abdominal
pain in five patients. Serum IgG4 levels were elevated in
only three of eight patients, and the levels were not
markedly elevated. Seven cases underwent resection
because preoperative diagnosis was difficult. In almost
all cases, abundant infiltration of IgG4-positive plasma
cells and an elevated ratio of IgG4- and IgG-positive
plasma cells (40%) was detected. Case 2, as diagnosed
by biopsy, was successfully treated with steroids. Other
organ involvement was not seen except for case 7.
Most patients with SM are symptomatic, with abdo-
minal pain or a palpable abdominal mass being the most
common clinical manifestations [1, 2, 8]. SM symptoms
are caused by a direct mechanical effect of the mass on
the bowels, vessels, and lymphatics, resulting in abdo-
minal pain, bowel obstruction, ischemia, and ascites.
Abdominal CT scanning is important for an accurate
diagnosis. In the absence of histological analysis, SM can
be diagnosed by CT findings of (1) hyperattenuating
mesenteric fat, especially at the root of the small-bowel
mesentery, (2) well-defined soft tissue nodules less than
5 mm in diameter surrounded by a fatty halo (fat ring
sign), and (3) a tumoral pseudo-capsule [7]. However,
the imaging appearances of SM vary depending on the
predominant tissue component (fat necrosis, inflammation,
or fibrosis) [20]. Therefore, SM may still be very difficult to
distinguish accurately from other mesenteric diseases, such
as gastrointestinal stromal tumor, malignant lymphoma,
metastatic carcinoid tumor, desmoid tumor, and metastatic
adenocarcinoma [5, 7–9].
The histological differential diagnosis in our patient
included leiomyosarcoma (desmin+), inflammatory myo-
fibroblastic tumor (ALK+/−, IgG4−), desmoid fibromato-
sis (β-catenin nuclear+), liposarcoma (CDK4+, MDM2+),
follicular dendritic tumor (CD21+, CD35+), and malig-
nant lymphoma (T/B cell marker, light chain restriction).
A definitive diagnosis of SM requires histological exami-
nation of biopsy or surgically excised tissue specimens,
unless other organs are apparently affected by IgG4-RD or
percutaneous needle biopsy can be easily performed.
No consensus has yet been reached for the treatment
for SM. Asymptomatic or mildly symptomatic SM may
be left untreated [1, 2]. Surgical exploration is advocated
in patients with life-threatening complications, such as
bowel obstruction or perforation, or if there is high
suspicion of an alternative diagnosis, such as malignancy.
Surgical intervention, predominantly incomplete resection
of SM, did not resolve symptoms or prevent disease
progression [2]. The effects of complete resection remain
unknown, as complete resection is frequently prevented
by vessel involvement. The patient described in this report
underwent complete resection of SM and partial ileal
resection, both for accurate diagnosis and for removal of
the cause of bowel obstruction. Surgery resulted in good
postoperative outcomes, without recurrence of the disease
or symptoms after about 4 years of follow-up. Medical
treatment, including with corticosteroids, tamoxifen,
cyclophosphamide, and azathioprine, has also shown good
Table 1 Summary of the clinicopathological features of IgG4-related sclerosing mesenteritis
Case Age Sex Chief
complaint















1 [10] 46 M NA Resection 7 NA − NA >100 <1/3 None ND
2 [12] 42 M Incidental Resection 4 119 − NA 60 40 None ND
3 [11] 82 F Abdominal
pain
Resection 11.7 171a − + 130 75.9 None ND
4 [13] 53 M Abdominal
pain
Resection 7 127a + + 74.8 64 None ND
5 [17] 7 F Abdominal
pain
Biopsy NA 149 − NA NA 52 None Effective
6 [18] 64 M Abdominal
pain
Resection 6 81a + + 38 80 Retroperitoneal
fibrosis
ND
7 [19] 70 F Abdominal
mass





Resection 2.6 114a + + 253 50 None ND
NA not available, ND not done, HPF high-powered field
aThe data after surgery
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results [1–3], although medical treatment for SM has not
been standardized. If SM is a manifestation of IgG4-RD,
corticosteroids may be promising.
Conclusions
SM may be associated with IgG4-RD in some patients.
Although the accurate diagnosis of SM remains difficult
in the absence of histological examination, IgG4-RD
should be included in the differential diagnosis of un-
known mesenteric tumors. Corticosteroids may be ef-
fective in these patients, thereby avoiding unnecessary
surgery.
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